Early Lactate Clearance Rate in Sepsis
Overview
To assess the Influence of early lactate clearance rate monitoring in patients with sepsis.
Full Title of Study: “Monitoring and Guidance of Early Lactate Clearance Rate in Patients With Sepsis”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: January 31, 2020
Interventions
- Diagnostic Test: lactate clearance
- Lactate clearance rate was monitored within 6 hours after admission
Arms, Groups and Cohorts
- lactate group
- Lactate early guide resuscitation
- control group
- early guide resuscitation without lactate
Clinical Trial Outcome Measures
Primary Measures
- In-hospital 60days mortality
- Time Frame: In-hospital 60 days
- In-hospital up to 60 days mortality of sepsis
- ICU mortality
- Time Frame: up to 30 days
- ICU up to 30 days mortality of sepsis
Participating in This Clinical Trial
Inclusion Criteria
- All patients whose blood lactate level reached or exceeded 2.0 mEq / L Exclusion Criteria:
- Incomplete clinical data
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- The Second Hospital of Hebei Medical University
- Provider of Information About this Clinical Study
- Principal Investigator: Fei Tong, Director – The Second Hospital of Hebei Medical University
- Overall Contact(s)
- Fei Tong, Dr., +8615803210603, tongfei168@163.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.